ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

The View Forom The White House On Research Funding

August 16, 1991

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI

October 29, 1976

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986